25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Heron Therapeutics Inc
Buy, Hold or Sell?

Let's analyze Heron Therapeutics Inc together

I guess you are interested in Heron Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Heron Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Heron Therapeutics Inc

I send you an email if I find something interesting about Heron Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Heron Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Heron Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€-0.20
Expected worth in 1 year
€-0.20
How sure are you?
35.7%

+ What do you gain per year?

Total Gains per Share
€0.00
Return On Investment
0.2%

For what price can you sell your share?

Current Price per Share
€2.11
Expected price per share
€1.581 - €2.522
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Heron Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
€2.11
Intrinsic Value Per Share
€11.06 - €13.60
Total Value Per Share
€10.86 - €13.39

2.2. Growth of Heron Therapeutics Inc (5 min.)




Is Heron Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$33.6m-$28.1m-$8.2m-22.6%

How much money is Heron Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.3m-$27.6m$24.2m714.1%
Net Profit Margin-10.1%-88.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Heron Therapeutics Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Heron Therapeutics Inc?

Welcome investor! Heron Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Heron Therapeutics Inc.

First you should know what it really means to hold a share of Heron Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Heron Therapeutics Inc is €2.112. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Heron Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Heron Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-0.20. Based on the TTM, the Book Value Change Per Share is €0.00 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Heron Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.021.1%-0.02-1.1%-0.22-10.3%-0.26-12.5%-0.26-12.5%
Usd Book Value Change Per Share0.042.0%0.000.1%-0.08-4.0%-0.02-0.7%-0.02-0.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.042.0%0.000.1%-0.08-4.0%-0.02-0.7%-0.02-0.7%
Usd Price Per Share1.58-2.41-1.34-3.53-3.53-
Price to Earnings Ratio16.45--11.22--2.37--5.28--5.28-
Price-to-Total Gains Ratio37.33-387.78--15.62-102.64-102.64-
Price to Book Ratio-7.16--10.04--7.92-0.38-0.38-
Price-to-Total Gains Ratio37.33-387.78--15.62-102.64-102.64-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.292576
Number of shares436
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.02
Usd Total Gains Per Share0.00-0.02
Gains per Quarter (436 shares)0.52-6.89
Gains per Year (436 shares)2.10-27.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102-80-28-38
204-60-55-66
306-40-83-94
408-20-110-122
501000-138-150
601320-165-178
701540-193-206
801760-220-234
901980-248-262
10021100-276-290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.013.00.07.1%1.013.00.07.1%1.013.00.07.1%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%5.09.00.035.7%5.09.00.035.7%5.09.00.035.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.014.00.0%0.00.014.00.0%0.00.014.00.0%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%5.09.00.035.7%5.09.00.035.7%5.09.00.035.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Heron Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0390.001+3433%-0.078+300%-0.015+137%-0.015+137%
Book Value Per Share---0.204-0.221+8%-0.195-4%0.029-795%0.029-795%
Current Ratio--2.2852.353-3%2.249+2%2.528-10%2.528-10%
Debt To Asset Ratio--1.1441.164-2%1.130+1%1.032+11%1.032+11%
Debt To Equity Ratio----0%-0%3.138-100%3.138-100%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value---23715746.08097375722.680-124%-63188599.900+166%152997465.751-116%152997465.751-116%
Eps--0.022-0.021+193%-0.201+1007%-0.244+1200%-0.244+1200%
Ev To Ebitda Ratio--infnannan%infnan%nannan%nannan%
Ev To Sales Ratio---0.1580.755-121%-0.550+248%1.753-109%1.753-109%
Free Cash Flow Per Share---0.075-0.037-51%-0.114+52%-0.197+162%-0.197+162%
Free Cash Flow To Equity Per Share---0.073-0.035-51%-0.026-65%-0.129+78%-0.129+78%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--13.597--------
Intrinsic Value_10Y_min--11.060--------
Intrinsic Value_1Y_max---0.330--------
Intrinsic Value_1Y_min---0.325--------
Intrinsic Value_3Y_max--0.298--------
Intrinsic Value_3Y_min--0.258--------
Intrinsic Value_5Y_max--2.481--------
Intrinsic Value_5Y_min--2.192--------
Market Cap--222058571.520335807385.380-34%163951453.800+35%382350998.551-42%382350998.551-42%
Net Profit Margin--0.090-0.101+213%-0.885+1085%-1.132+1360%-1.132+1360%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.1481.356-15%2.404-52%2.546-55%2.546-55%
Pb Ratio-10.362-45%-7.163-10.044+40%-7.915+10%0.385-1961%0.385-1961%
Pe Ratio23.799+31%16.452-11.224+168%-2.372+114%-5.282+132%-5.282+132%
Price Per Share2.112+31%1.4602.219-34%1.231+19%3.256-55%3.256-55%
Price To Free Cash Flow Ratio-7.020-45%-4.853-3.841-21%5.531-188%-1.018-79%-1.018-79%
Price To Total Gains Ratio53.999+31%37.329387.779-90%-15.618+142%102.639-64%102.639-64%
Quick Ratio--1.2291.403-12%1.2330%1.256-2%1.256-2%
Return On Assets--0.016-0.016+200%-0.129+919%-0.114+829%-0.114+829%
Return On Equity----0%-0%-0.5100%-0.5100%
Total Gains Per Share--0.0390.001+3433%-0.078+300%-0.015+137%-0.015+137%
Usd Book Value---33649741.453-36339140.865+8%-28116948.387-16%-1655438.084-95%-1655438.084-95%
Usd Book Value Change Per Share--0.0420.001+3433%-0.085+300%-0.016+137%-0.016+137%
Usd Book Value Per Share---0.221-0.240+8%-0.212-4%0.032-795%0.032-795%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value---25743442.370105701346.969-124%-68591225.191+166%166078749.073-116%166078749.073-116%
Usd Eps--0.024-0.022+193%-0.218+1007%-0.265+1200%-0.265+1200%
Usd Free Cash Flow---12417535.567-6058523.403-51%-15082935.877+21%-23831322.961+92%-23831322.961+92%
Usd Free Cash Flow Per Share---0.082-0.040-51%-0.124+52%-0.214+162%-0.214+162%
Usd Free Cash Flow To Equity Per Share---0.079-0.038-51%-0.028-65%-0.140+78%-0.140+78%
Usd Market Cap--241044579.385364518916.830-34%177969303.100+35%415042008.928-42%415042008.928-42%
Usd Price Per Share2.293+31%1.5852.408-34%1.336+19%3.534-55%3.534-55%
Usd Profit--3662863.004-3394873.027+193%-27638716.273+855%-29514396.120+906%-29514396.120+906%
Usd Revenue--40779474.79136069900.935+13%31759812.139+28%30205013.147+35%30205013.147+35%
Usd Total Gains Per Share--0.0420.001+3433%-0.085+300%-0.016+137%-0.016+137%
 EOD+4 -2MRQTTM+17 -16YOY+23 -105Y+20 -1410Y+20 -14

3.3 Fundamental Score

Let's check the fundamental score of Heron Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1523.799
Price to Book Ratio (EOD)Between0-1-10.362
Net Profit Margin (MRQ)Greater than00.090
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.229
Current Ratio (MRQ)Greater than12.285
Debt to Asset Ratio (MRQ)Less than11.144
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.016
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Heron Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.832
Ma 20Greater thanMa 501.869
Ma 50Greater thanMa 1001.706
Ma 100Greater thanMa 2001.571
OpenGreater thanClose2.174
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Heron Therapeutics Inc

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Heron Therapeutics Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Heron Therapeutics Inc to the  industry mean.
  • A Net Profit Margin of 9.0% means that €0.09 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Heron Therapeutics Inc:

  • The MRQ is 9.0%. The company is making a profit. +1
  • The TTM is -10.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ9.0%TTM-10.1%+19.1%
TTM-10.1%YOY-88.5%+78.4%
TTM-10.1%5Y-113.2%+103.1%
5Y-113.2%10Y-113.2%0.0%
4.3.1.2. Return on Assets

Shows how efficient Heron Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Heron Therapeutics Inc to the  industry mean.
  • 1.6% Return on Assets means that Heron Therapeutics Inc generated €0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Heron Therapeutics Inc:

  • The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is -1.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.6%TTM-1.6%+3.1%
TTM-1.6%YOY-12.9%+11.3%
TTM-1.6%5Y-11.4%+9.9%
5Y-11.4%10Y-11.4%0.0%
4.3.1.3. Return on Equity

Shows how efficient Heron Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Heron Therapeutics Inc to the  industry mean.
  • 0.0% Return on Equity means Heron Therapeutics Inc generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Heron Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-51.0%+51.0%
5Y-51.0%10Y-51.0%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Heron Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Heron Therapeutics Inc is operating .

  • Measures how much profit Heron Therapeutics Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Heron Therapeutics Inc to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Heron Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Heron Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.15 means that the operating costs are €1.15 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Heron Therapeutics Inc:

  • The MRQ is 1.148. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.356. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.148TTM1.356-0.208
TTM1.356YOY2.404-1.047
TTM1.3565Y2.546-1.190
5Y2.54610Y2.5460.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Heron Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Heron Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 2.29 means the company has €2.29 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Heron Therapeutics Inc:

  • The MRQ is 2.285. The company is able to pay all its short-term debts. +1
  • The TTM is 2.353. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.285TTM2.353-0.068
TTM2.353YOY2.249+0.105
TTM2.3535Y2.528-0.175
5Y2.52810Y2.5280.000
4.4.3.2. Quick Ratio

Measures if Heron Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Heron Therapeutics Inc to the  industry mean.
  • A Quick Ratio of 1.23 means the company can pay off €1.23 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Heron Therapeutics Inc:

  • The MRQ is 1.229. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.403. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.229TTM1.403-0.174
TTM1.403YOY1.233+0.170
TTM1.4035Y1.256+0.147
5Y1.25610Y1.2560.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Heron Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Heron Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Heron Therapeutics Inc to industry mean.
  • A Debt to Asset Ratio of 1.14 means that Heron Therapeutics Inc assets are financed with 114.4% credit (debt) and the remaining percentage (100% - 114.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Heron Therapeutics Inc:

  • The MRQ is 1.144. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.164. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.144TTM1.164-0.019
TTM1.164YOY1.130+0.033
TTM1.1645Y1.032+0.132
5Y1.03210Y1.0320.000
4.5.4.2. Debt to Equity Ratio

Measures if Heron Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Heron Therapeutics Inc to the  industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Heron Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y3.138-3.138
5Y3.13810Y3.1380.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Heron Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Heron Therapeutics Inc to the  industry mean.
  • A PE ratio of 16.45 means the investor is paying €16.45 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Heron Therapeutics Inc:

  • The EOD is 23.799. Based on the earnings, the company is fair priced.
  • The MRQ is 16.452. Based on the earnings, the company is fair priced.
  • The TTM is -11.224. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD23.799MRQ16.452+7.347
MRQ16.452TTM-11.224+27.676
TTM-11.224YOY-2.372-8.852
TTM-11.2245Y-5.282-5.941
5Y-5.28210Y-5.2820.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Heron Therapeutics Inc:

  • The EOD is -7.020. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.853. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.841. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.020MRQ-4.853-2.167
MRQ-4.853TTM-3.841-1.012
TTM-3.841YOY5.531-9.372
TTM-3.8415Y-1.018-2.823
5Y-1.01810Y-1.0180.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Heron Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of -7.16 means the investor is paying €-7.16 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Heron Therapeutics Inc:

  • The EOD is -10.362. Based on the equity, the company is expensive. -2
  • The MRQ is -7.163. Based on the equity, the company is expensive. -2
  • The TTM is -10.044. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.362MRQ-7.163-3.199
MRQ-7.163TTM-10.044+2.880
TTM-10.044YOY-7.915-2.128
TTM-10.0445Y0.385-10.429
5Y0.38510Y0.3850.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Income before Tax  -9,8796,968-2,911-5,596-8,5074,041-4,4667,8403,374
Net Income  -9,8796,968-2,911-5,596-8,5074,041-4,4667,8403,374
Operating Income  -9,4154,995-4,420-1,517-5,9371,830-4,1077,9513,844
Net Income from Continuing Operations  -9,8796,968-2,911-5,596-8,5074,041-4,4667,8403,374



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets233,147
Total Liabilities266,798
Total Stockholder Equity-33,651
 As reported
Total Liabilities 266,798
Total Stockholder Equity+ -33,651
Total Assets = 233,147

Assets

Total Assets233,147
Total Current Assets209,014
Long-term Assets24,133
Total Current Assets
Cash And Cash Equivalents 25,802
Short-term Investments 33,481
Net Receivables 78,881
Inventory 53,160
Other Current Assets 17,690
Total Current Assets  (as reported)209,014
Total Current Assets  (calculated)209,014
+/-0
Long-term Assets
Property Plant Equipment 17,650
Long-term Assets Other 6,483
Long-term Assets  (as reported)24,133
Long-term Assets  (calculated)24,133
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities91,457
Long-term Liabilities175,341
Total Stockholder Equity-33,651
Total Current Liabilities
Accounts payable 11,709
Total Current Liabilities  (as reported)91,457
Total Current Liabilities  (calculated)11,709
+/- 79,748
Long-term Liabilities
Long term Debt 174,726
Capital Lease Obligations Min Short Term Debt3,037
Long-term Liabilities Other 615
Long-term Liabilities  (as reported)175,341
Long-term Liabilities  (calculated)178,378
+/- 3,037
Total Stockholder Equity
Total Stockholder Equity (as reported)-33,651
Total Stockholder Equity (calculated)0
+/- 33,651
Other
Capital Stock1,521
Common Stock Shares Outstanding 152,095
Net Debt 148,924
Net Invested Capital 141,075
Net Working Capital 117,557
Property Plant and Equipment Gross 35,497



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-30
> Total Assets 
352,388
305,706
273,723
243,965
271,952
250,951
220,878
201,224
229,199
222,506
217,887
218,136
220,777
233,147
233,147220,777218,136217,887222,506229,199201,224220,878250,951271,952243,965273,723305,706352,388
   > Total Current Assets 
315,052
254,423
222,593
194,209
223,804
205,435
178,159
165,280
193,979
188,774
185,903
191,168
195,187
209,014
209,014195,187191,168185,903188,774193,979165,280178,159205,435223,804194,209222,593254,423315,052
       Cash And Cash Equivalents 
159,570
90,541
56,911
48,609
50,438
15,364
27,090
13,462
34,859
28,677
20,450
18,386
25,741
25,802
25,80225,74118,38620,45028,67734,85913,46227,09015,36450,43848,60956,91190,541159,570
       Short-term Investments 
43,250
67,039
54,999
34,929
71,308
69,488
32,932
19,782
42,553
51,732
51,074
48,961
45,149
33,481
33,48145,14948,96151,07451,73242,55319,78232,93269,48871,30834,92954,99967,03943,250
       Net Receivables 
43,086
35,499
41,103
40,303
42,188
52,049
51,448
76,693
63,795
60,137
65,322
73,708
67,039
78,881
78,88167,03973,70865,32260,13763,79576,69351,44852,04942,18840,30341,10335,49943,086
       Inventory 
41,502
48,382
56,470
61,318
52,239
54,573
52,059
44,623
42,007
42,110
42,473
42,864
45,950
53,160
53,16045,95042,86442,47342,11042,00744,62352,05954,57352,23961,31856,47048,38241,502
   > Long-term Assets 
37,336
51,283
51,130
49,756
48,148
45,516
42,719
35,944
35,220
33,732
31,984
26,968
25,590
24,133
24,13325,59026,96831,98433,73235,22035,94442,71945,51648,14849,75651,13051,28337,336
       Property Plant Equipment 
0
0
0
0
30,823
29,805
28,583
27,361
26,854
25,604
24,100
20,038
18,883
17,650
17,65018,88320,03824,10025,60426,85427,36128,58329,80530,8230000
       Long-term Assets Other 
346
17,720
17,977
17,534
17,325
15,711
14,136
8,583
8,366
8,128
7,884
6,930
6,707
6,483
6,4836,7076,9307,8848,1288,3668,58314,13615,71117,32517,53417,97717,720346
> Total Liabilities 
233,545
228,136
249,765
265,701
249,502
237,379
232,307
240,508
256,985
256,479
251,653
256,076
260,782
266,798
266,798260,782256,076251,653256,479256,985240,508232,307237,379249,502265,701249,765228,136233,545
   > Total Current Liabilities 
72,296
71,058
93,001
109,498
93,876
82,355
77,900
86,722
79,745
79,685
75,378
80,317
85,544
91,457
91,45785,54480,31775,37879,68579,74586,72277,90082,35593,876109,49893,00171,05872,296
       Accounts payable 
5,885
3,873
8,226
13,804
6,547
3,588
4,065
1,957
1,860
3,799
837
10,226
10,188
11,709
11,70910,18810,2268373,7991,8601,9574,0653,5886,54713,8048,2263,8735,885
   > Long-term Liabilities 
161,249
157,078
156,764
156,203
155,626
155,024
154,407
153,786
177,240
176,794
176,275
175,759
175,238
175,341
175,341175,238175,759176,275176,794177,240153,786154,407155,024155,626156,203156,764157,078161,249
       Long term Debt 
149,032
149,082
149,132
149,182
149,234
149,284
149,335
149,387
173,462
173,753
173,989
174,229
174,475
174,726
174,726174,475174,229173,989173,753173,462149,387149,335149,284149,234149,182149,132149,082149,032
       Capital Lease Obligations Min Short Term Debt
15,468
10,413
9,875
9,329
8,771
8,193
7,593
6,738
6,536
5,875
5,182
4,483
3,771
3,037
3,0373,7714,4835,1825,8756,5366,7387,5938,1938,7719,3299,87510,41315,468
       Long-term Liabilities Other 
0
0
241
241
241
241
241
241
241
241
241
241
241
615
61524124124124124124124124124124124100
> Total Stockholder Equity
118,843
77,570
23,958
-21,736
22,450
13,572
-11,429
-39,284
-27,786
-33,973
-33,766
-37,940
-40,005
-33,651
-33,651-40,005-37,940-33,766-33,973-27,786-39,284-11,42913,57222,450-21,73623,95877,570118,843
   Common Stock00000000000000
   Retained Earnings Total Equity00000000000000
   Accumulated Other Comprehensive Income 00000000000000
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 00000000000000



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue144,285
Cost of Revenue-38,648
Gross Profit105,637105,637
 
Operating Income (+$)
Gross Profit105,637
Operating Expense-155,813
Operating Income-11,528-50,176
 
Operating Expense (+$)
Research Development16,683
Selling General Administrative100,482
Selling And Marketing Expenses-
Operating Expense155,813117,165
 
Net Interest Income (+$)
Interest Income3,550
Interest Expense-6,032
Other Finance Cost-0
Net Interest Income-2,482
 
Pretax Income (+$)
Operating Income-11,528
Net Interest Income-2,482
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-13,580-11,958
EBIT - interestExpense = -6,032
-13,580
-7,548
Interest Expense6,032
Earnings Before Interest and Taxes (EBIT)--7,548
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-13,580
Tax Provision--
Net Income From Continuing Ops-13,580-13,580
Net Income-13,580
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net4302,482
 

Technical Analysis of Heron Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Heron Therapeutics Inc. The general trend of Heron Therapeutics Inc is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Heron Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Heron Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.364 < 2.504 < 2.522.

The bearish price targets are: 1.758 > 1.68 > 1.581.

Tweet this
Heron Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Heron Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Heron Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Heron Therapeutics Inc. The current macd is 0.14103726.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Heron Therapeutics Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Heron Therapeutics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Heron Therapeutics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Heron Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartHeron Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Heron Therapeutics Inc. The current adx is 28.93.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Heron Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Heron Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Heron Therapeutics Inc. The current sar is 2.3477244.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Heron Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Heron Therapeutics Inc. The current rsi is 61.83. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Heron Therapeutics Inc Daily Relative Strength Index (RSI) ChartHeron Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Heron Therapeutics Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Heron Therapeutics Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Heron Therapeutics Inc Daily Stochastic Oscillator ChartHeron Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Heron Therapeutics Inc. The current cci is 64.77.

Heron Therapeutics Inc Daily Commodity Channel Index (CCI) ChartHeron Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Heron Therapeutics Inc. The current cmo is 21.77.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Heron Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartHeron Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Heron Therapeutics Inc. The current willr is -32.18390805.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Heron Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Heron Therapeutics Inc Daily Williams %R ChartHeron Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Heron Therapeutics Inc.

Heron Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Heron Therapeutics Inc. The current atr is 0.09888634.

Heron Therapeutics Inc Daily Average True Range (ATR) ChartHeron Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Heron Therapeutics Inc. The current obv is 47,631.

Heron Therapeutics Inc Daily On-Balance Volume (OBV) ChartHeron Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Heron Therapeutics Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Heron Therapeutics Inc Daily Money Flow Index (MFI) ChartHeron Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Heron Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-03-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Heron Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Heron Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.832
Ma 20Greater thanMa 501.869
Ma 50Greater thanMa 1001.706
Ma 100Greater thanMa 2001.571
OpenGreater thanClose2.174
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Heron Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Heron Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Heron Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Heron Therapeutics Inc

I send you an email if I find something interesting about Heron Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Heron Therapeutics Inc.

Receive notifications about Heron Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.